INS and diabetes mellitus: Another possible source of error was the classification of all participants with fasting glucose ≥ 7.0 mmol/L (126 mg/dL) or use of oral medication or insulin as individuals with type 2 DM, with no stratification among the other types of DM or other cases that demand the use of oral hypoglycemic agents.